Aleniglipron
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
Gasherbrum Bio, Inc · Phase 3 · Recruiting · Enrollment 3600
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| aleniglipron Arm 1 | Obesity or overweight | n/r | 76 | n/r | n/r |
| aleniglipron Arm 2 | Obesity or overweight | n/r | 76 | n/r | n/r |
| aleniglipron Arm 3 | Obesity or overweight | n/r | 76 | n/r | n/r |
| Placebo Arm 4 | Obesity or overweight | n/r | 76 | n/r | n/r |